INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,110,287 | -25.2% | 66,739 | -3.5% | 0.01% | -12.5% |
| Q2 2023 | $2,820,997 | +15.8% | 69,176 | +5.9% | 0.01% | +14.3% |
| Q1 2023 | $2,435,073 | +1.7% | 65,336 | -4.8% | 0.01% | -12.5% |
| Q4 2022 | $2,394,466 | -37.4% | 68,629 | +0.4% | 0.01% | -33.3% |
| Q3 2022 | $3,824,000 | +2.1% | 68,332 | -5.6% | 0.01% | +20.0% |
| Q2 2022 | $3,747,000 | -44.1% | 72,398 | -21.5% | 0.01% | -28.6% |
| Q1 2022 | $6,700,000 | -38.5% | 92,200 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $10,902,000 | -23.9% | 92,200 | -13.7% | 0.02% | -30.0% |
| Q3 2021 | $14,335,000 | +2.7% | 106,858 | +23.9% | 0.03% | +3.4% |
| Q2 2021 | $13,963,000 | +121.6% | 86,242 | +9.9% | 0.03% | +123.1% |
| Q1 2021 | $6,300,000 | +64.7% | 78,500 | +11.7% | 0.01% | +44.4% |
| Q4 2020 | $3,824,000 | +173.5% | 70,300 | 0.0% | 0.01% | +200.0% |
| Q3 2020 | $1,398,000 | +9.2% | 70,300 | +15.4% | 0.00% | -25.0% |
| Q2 2020 | $1,280,000 | +75.3% | 60,900 | +2.0% | 0.00% | +100.0% |
| Q1 2020 | $730,000 | -8.9% | 59,700 | +9.3% | 0.00% | 0.0% |
| Q4 2019 | $801,000 | +9.9% | 54,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $729,000 | -7.6% | 54,600 | +13.3% | 0.00% | 0.0% |
| Q2 2019 | $789,000 | -4.6% | 48,200 | -0.4% | 0.00% | 0.0% |
| Q1 2019 | $827,000 | +76.0% | 48,400 | +40.7% | 0.00% | 0.0% |
| Q4 2018 | $470,000 | -51.4% | 34,400 | +1.8% | 0.00% | -33.3% |
| Q3 2018 | $967,000 | +4.5% | 33,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $925,000 | +338.4% | 33,800 | +238.0% | 0.00% | +200.0% |
| Q1 2018 | $211,000 | +9.9% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $192,000 | -22.6% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $248,000 | +55.0% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $160,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |